Researchers Identify Enzyme Driving Bladder Cancer Resistance
A study finds that the USP3 enzyme promotes chemoresistance by stabilizing proteins that repair DNA damage.
Updated on Oct. 24, 2026 in Cancer
Scientists have discovered that the USP3 enzyme plays a critical role in bladder cancer progression and resistance to chemotherapy. By stabilizing NPM1 proteins, the enzyme helps cancer cells maintain chromatin homeostasis and evade the effects of cisplatin treatment.
Why it matters
Understanding the signaling pathway between USP3 and NPM1 provides a new potential target for therapies aimed at treating advanced bladder cancer. This mechanism helps explain why some cancer cells are able to survive aggressive chemotherapy regimens.
Researchers observed that USP3 removes K48-linked polyubiquitination from NPM1 to prevent its degradation. Silencing this enzyme in vitro and in vivo models significantly inhibited cell proliferation and reduced tumor growth.
The players
USP3
This is an enzyme identified as a key driver of chemoresistance in bladder cancer cells.
NPM1
This protein is stabilized by USP3 to maintain chromatin stability and promote tumor cell survival.
The details
The USP3-NPM1 signaling axis facilitates nucleosome assembly, which acts as a buffer against DNA damage caused by common treatments like cisplatin. Upregulation of this enzyme in cancer tissues is directly correlated with poor patient outcomes.
Timeline
October 24, 2026: The research findings were published.
The Big Picture
This discovery updates the current understanding of protein stabilization pathways in bladder cancer. It provides a foundational mechanism that explains how cancer cells develop resistance to standard chemotherapy treatments.
While this research remains at the laboratory stage, identifying this enzyme offers a potential new avenue for future drug development. Patients may eventually see therapies that target this specific pathway to improve the effectiveness of existing cisplatin treatments.
The takeaway
This research reveals how the USP3 enzyme helps cancer cells repair damage, offering a promising target to overcome treatment resistance. Future therapeutic strategies focusing on this pathway could significantly improve the success rates of chemotherapy in bladder cancer patients.
Further reading
Learn more about advancements in oncology research by visiting our Cancer section.
More information
For detailed methodology and results, read the full peer-reviewed research article.
Source note: This article includes information reported by Nature.
